pharma · Multiple Myeloma · Ovarian Cancer · CASIF
CASI Pharmaceuticals
CASI Pharmaceuticals trial registry — 24 ClinicalTrials.gov studies with program phase, status, and indication context.
601 Gateway Blvd, San Francisco, CA 94080, US HQ
44 Employees
Public company Type
CASIF · NYSE Ticker
Company details
- Status
- Public
- HQ
- 601 Gateway Blvd, San Francisco, CA 94080, US
- Employees
- 44
- Programs
- 22
- Drugs
- 11
- Patents
- 2
CASI Pharmaceuticals clinical trials
Registry index of 24 ClinicalTrials.gov studies linked to CASI Pharmaceuticals programs — each row shows trial ID, program name, phase, status, and indication.
CASI Pharmaceuticals trial registry — 24 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for CASI Pharmaceuticals.
-
ME-CLN-002 — Phase 2
Clinical update -
melphalan hydrochloride for injection — Approved
Clinical update -
2-methoxyestradiol — Phase 2
Clinical update -
recombinant human Angiostatin protein — Phase 2
Clinical update -
MKC-1 — Phase 1
Clinical update -
ENMD-2076 — Phase 1
Clinical update -
CID-103 — Phase 2
Clinical update -
ENMD-2076 — Phase 2
Clinical update